Slow gonorrhea is chronic lymphocytic leukemia, it is recommended to go to the hematology department to improve the examination, can choose ibrutinib, fludarabine + cyclophosphamide + rituximab and other programs. The specific program should be decided according to the actual situation of the patient.
Chronic lymphocytic leukemia is a mature B-lymphocyte clonal proliferative tumor that mainly occurs in middle-aged and old-aged people, and the specific treatment plan should be chosen after perfecting the relevant examination, clarifying the condition to determine that there is a therapeutic indication, and evaluating the physical status.
If the patient does not have del(17p) or TP53 gene mutation and is ≤65 years old, ibrutinib, zebrutinib, fludarabine + cyclophosphamide + rituximab (FCR regimen) can be chosen; if the patient is ≥65 years old, bendamustine + rituximab (BR regimen) can be chosen for treatment.
If the patient has del (17p) or TP53 gene mutation, he/she can choose Ibrutinib, Zebutinib, Obutinib and other drugs for treatment.
All of the above drugs should be used under the guidance of the doctor after fully communicating with the doctor about the treatment plan, and attention should be paid to the close monitoring of patients’ adverse reactions. If there is any discomfort in the use, timely feedback should be provided.